Albumin fusion renders thioredoxin an effective anti-oxidative and anti-inflammatory agent for preventing cisplatin-induced nephrotoxicity

Biochimica et Biophysica Acta - General Subjects

Volumn 1840, Issue 3, 2014, Pages 1152-1162

  Kodama, Azusa ^a   Watanabe, Hiroshi ^a   Tanaka, Ryota ^a   Kondo, Masumi ^b   Chuang, Victor Tuan Giam ^c   Wu, Qiong ^b   Endo, Masayuki ^b   Ishima, Yu ^a   Fukagawa, Masafumi ^b   Otagiri, Masaki ^d   Maruyama, Toru ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c CURTIN UNIVERSITY   (Australia)

^d SOJO UNIVERSITY   (Japan)

Author keywords

Acute kidney injury; Cisplatin nephrotoxicity; Fusion protein; Inflammation; Oxidative stress; Thioredoxin

Indexed keywords

ACETYLCYSTEINE; ACETYLGLUCOSAMINIDASE; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; CISPLATIN; CREATININE; FLUORESCEIN ISOTHIOCYANATE; GLUTATHIONE; HUMAN SERUM ALBUMIN THIOREDOXIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; NITROGEN; PROTECTIVE AGENT; REACTIVE OXYGEN METABOLITE; THIOREDOXIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; HISTOPATHOLOGY; KIDNEY DYSFUNCTION; MALE; MOUSE; NEPHROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PICHIA; PRIORITY JOURNAL; RENAL PROTECTION; UREA NITROGEN BLOOD LEVEL;

ACUTE KIDNEY INJURY; CISPLATIN NEPHROTOXICITY; FUSION PROTEIN; INFLAMMATION; OXIDATIVE STRESS; THIOREDOXIN;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; APOPTOSIS; CISPLATIN; HUMANS; KIDNEY; MALE; MICE; MICE, INBRED ICR; REACTIVE OXYGEN SPECIES; SERUM ALBUMIN; THIOREDOXINS;

EID: 84891692691     PISSN: 03044165     EISSN: 18728006     Source Type: Journal    
DOI: 10.1016/j.bbagen.2013.12.007     Document Type: Article

References (41)

1. R.W. Schrier Cancer therapy and renal injury J. Clin. Invest. 110 2002 743 745
2. E.S. El-Sayed, O.M. Abd El-Raouf, H.M. Fawzy, and M.F. Manie Comparative study of the possible protective effects of cinnamic acid and cinnamaldehyde on cisplatin-induced nephrotoxicity in rats J. Biochem. Mol. Toxicol. 2013
3. D.C. Dobyan, J. Levi, C. Jacobs, J. Kosek, and M.W. Weiner Mechanism of cis-platinum nephrotoxicity: II. Morphologic observations J. Pharmacol. Exp. Ther. 213 1980 551 556 (Pubitemid 10085160)
4. M.K. Kuhlmann, G. Burkhardt, and H. Köhler Insights into potential cellular mechanisms of cisplatin nephrotoxicity and their clinical application Nephrol. Dial. Transplant. 12 1997 2478 2480 (Pubitemid 27520658)
5. I. Arany, and R.L. Safirstein Cisplatin nephrotoxicity Semin. Nephrol. 23 2003 460 464 (Pubitemid 37176691)
6. G. Ciarimboli, T. Ludwig, D. Lang, H. Pavenstädt, H. Koepsell, H.J. Piechota, J. Haier, U. Jaehde, J. Zisowsky, and E. Schlatter Cisplatin nephrotoxicity is critically mediated via the human organic cation transporter 2 Am. J. Pathol. 167 2005 1477 1484 (Pubitemid 41713303)
7. H. Matsushima, K. Yonemura, K. Ohishi, and A. Hishida The role of oxygen free radicals in cisplatin-induced acute renal failure in rats J. Lab. Clin. Med. 131 1998 518 526 (Pubitemid 28278570)
8. C.A. Davis, H.S. Nick, and A. Agarwal Manganese superoxide dismutase attenuates Cisplatin-induced renal injury: importance of superoxide J. Am. Soc. Nephrol. 12 2001 2683 2690 (Pubitemid 33115415)
9. Y.I. Chirino, R. Hernández-Pando, and J. Pedraza-Chaverrí Peroxynitrite decomposition catalyst ameliorates renal damage and protein nitration in cisplatin-induced nephrotoxicity in rats BMC Pharmacol. 4 2004 20
10. Y.I. Chirino, J. Trujillo, D.J. Sánchez-González, C.M. Martínez-Martínez, C. Cruz, N.A. Bobadilla, and J. Pedraza-Chaverri Selective iNOS inhibition reduces renal damage induced by cisplatin Toxicol. Lett. 176 2008 48 57 (Pubitemid 50008205)
11. T. Ludwig, C. Riethmüller, M. Gekle, G. Schwerdt, and H. Oberleithner Nephrotoxicity of platinum complexes is related to basolateral organic cation transport Kidney Int. 66 2004 196 202 (Pubitemid 38870095)
12. J. Yamate, K. Sato, M. Ide, M. Nakanishi, M. Kuwamura, S. Sakuma, and S. Nakatsuji Participation of different macrophage populations and myofibroblastic cells in chronically developed renal interstitial fibrosis after cisplatin-induced renal injury in rats Vet. Pathol. 39 2002 322 333
13. S. Faubel, E.C. Lewis, L. Reznikov, D. Ljubanovic, T.S. Hoke, H. Somerset, D.J. Oh, L. Lu, C.L. Klein, C.A. Dinarello, and C.L. Edelstein Cisplatin-induced acute renal failure is associated with an increase in the cytokines interleukin (IL)-1beta, IL-18, IL-6, and neutrophil infiltration in the kidney J. Pharmacol. Exp. Ther. 322 2007 8 15 (Pubitemid 46956357)
14. Y. Kawai, T. Nakao, N. Kunimura, Y. Kohda, and M. Gemba Relationship of intracellular calcium and oxygen radicals to Cisplatin-related renal cell injury J. Pharmacol. Sci. 100 2006 65 72 (Pubitemid 43161616)
15. G.P. Kaushal, V. Kaushal, X. Hong, and S.V. Shah Role and regulation of activation of caspases in cisplatin-induced injury to renal tubular epithelial cells Kidney Int. 60 2001 1726 1736 (Pubitemid 32999977)
16. G. Ramesh, and W.B. Reeves p38 MAP kinase inhibition ameliorates cisplatin nephrotoxicity in mice Am. J. Physiol. Renal Physiol. 289 2005 F166 F174
17. C.L. Do Amaral, H.D. Francescato, T.M. Coimbra, R.S. Costa, J.D. Darin, L.M. Antunes, and M.e.L. Bianchi Resveratrol attenuates cisplatin-induced nephrotoxicity in rats Arch. Toxicol. 82 2008 363 370
18. R. Watanabe, H. Nakamura, H. Masutani, and J. Yodoi Anti-oxidative, anti-cancer and anti-inflammatory actions by thioredoxin 1 and thioredoxin-binding protein-2 Pharmacol. Ther. 127 2010 261 270
19. S. Ikuta, V.T. Chuang, Y. Ishima, K. Nakajou, M. Furukawa, H. Watanabe, T. Maruyama, and M. Otagiri Albumin fusion of thioredoxin - the production and evaluation of its biological activity for potential therapeutic applications J. Control. Release 147 2010 17 23
20. M. Furukawa, R. Tanaka, V.T. Chuang, Y. Ishima, K. Taguchi, H. Watanabe, T. Maruyama, and M. Otagiri Human serum albumin-thioredoxin fusion protein with long blood retention property is effective in suppressing lung injury J. Control. Release 154 2011 189 195
21. A. Kodama, H. Watanabe, R. Tanaka, H. Tanaka, V.T. Chuang, Y. Miyamoto, Q. Wu, M. Endo, K. Hamasaki, Y. Ishima, M. Fukagawa, M. Otagiri, and T. Maruyama A human serum albumin-thioredoxin fusion protein prevents experimental contrast-induced nephropathy Kidney Int. 83 2013 446 454
22. R. Tanaka, H. Watanabe, A. Kodama, V.T. Chuang, Y. Ishima, K. Hamasaki, K. Tanaka, T. Mizushima, M. Otagiri, and T. Maruyama Long-acting human serum albumin-thioredoxin fusion protein suppresses bleomycin-induced pulmonary fibrosis progression J. Pharmacol. Exp. Ther. 345 2013 271 283
23. X. Yao, K. Panichpisal, N. Kurtzman, and K. Nugent Cisplatin nephrotoxicity: a review Am. J. Med. Sci. 334 2007 115 124 (Pubitemid 47262919)
24. P. Mukhopadhyay, M. Rajesh, H. Pan, V. Patel, B. Mukhopadhyay, S. Bátkai, B. Gao, G. Haskó, and P. Pacher Cannabinoid-2 receptor limits inflammation, oxidative/nitrosative stress, and cell death in nephropathy Free Radic. Biol. Med. 48 2010 457 467
25. N.C. Schmitt, and E.W. Rubel Osteopontin does not mitigate cisplatin ototoxicity or nephrotoxicity in adult mice Otolaryngol. Head Neck Surg. 149 2013 614 620
26. K.C. Das, and C.K. Das Thioredoxin, a singlet oxygen quencher and hydroxyl radical scavenger: redox independent functions Biochem. Biophys. Res. Commun. 277 2000 443 447
27. S.W. Kang, H.Z. Chae, M.S. Seo, K. Kim, I.C. Baines, and S.G. Rhee Mammalian peroxiredoxin isoforms can reduce hydrogen peroxide generated in response to growth factors and tumor necrosis factor-alpha J. Biol. Chem. 273 1998 6297 6302 (Pubitemid 28144719)
28. M. Soriani, D. Pietraforte, and M. Minetti Antioxidant potential of anaerobic human plasma: role of serum albumin and thiols as scavengers of carbon radicals Arch. Biochem. Biophys. 312 1994 180 188 (Pubitemid 24243816)
29. G.J. Quinlan, S. Mumby, G.S. Martin, G.R. Bernard, J.M. Gutteridge, and T.W. Evans Albumin influences total plasma antioxidant capacity favorably in patients with acute lung injury Crit. Care Med. 32 2004 755 759 (Pubitemid 38340073)
30. M. Anraku, V.T. Chuang, T. Maruyama, and M. Otagiri Redox properties of serum albumin Biochim. Biophys. Acta 1830 2013 5465 5472
31. L. Tao, E. Gao, A. Hu, C. Coletti, Y. Wang, T.A. Christopher, B.L. Lopez, W. Koch, and X.L. Ma Thioredoxin reduces post-ischemic myocardial apoptosis by reducing oxidative/nitrative stress Br. J. Pharmacol. 149 2006 311 318 (Pubitemid 44453432)
32. G. Ramesh, and W.B. Reeves TNF-alpha mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity J. Clin. Invest. 110 2002 835 842
33. G. Ramesh, and W.B. Reeves TNFR2-mediated apoptosis and necrosis in cisplatin-induced acute renal failure Am. J. Physiol. Renal Physiol. 285 2003 F610 F618
34. H. Nakamura, L.A. Herzenberg, J. Bai, S. Araya, N. Kondo, Y. Nishinaka, and J. Yodoi Circulating thioredoxin suppresses lipopolysaccharide-induced neutrophil chemotaxis Proc. Natl. Acad. Sci. U. S. A. 98 2001 15143 15148 (Pubitemid 34013983)
35. H. Tamaki, H. Nakamura, A. Nishio, H. Nakase, S. Ueno, N. Uza, M. Kido, S. Inoue, S. Mikami, M. Asada, K. Kiriya, H. Kitamura, S. Ohashi, T. Fukui, K. Kawasaki, M. Matsuura, Y. Ishii, K. Okazaki, J. Yodoi, and T. Chiba Human thioredoxin-1 ameliorates experimental murine colitis in association with suppressed macrophage inhibitory factor production Gastroenterology 131 2006 1110 1121 (Pubitemid 44498706)
36. Y. Matsuo, and J. Yodoi Extracellular thioredoxin: a therapeutic tool to combat inflammation Cytokine Growth Factor Rev. 24 2013 345 353
37. G. Fujino, T. Noguchi, A. Matsuzawa, S. Yamauchi, M. Saitoh, K. Takeda, and H. Ichijo Thioredoxin and TRAF family proteins regulate reactive oxygen species-dependent activation of ASK1 through reciprocal modulation of the N-terminal homophilic interaction of ASK1 Mol. Cell. Biol. 27 2007 8152 8163 (Pubitemid 350234230)
38. M. Gekle Renal tubule albumin transport Annu. Rev. Physiol. 67 2005 573 594 (Pubitemid 40404502)
39. V. Tenten, S. Menzel, U. Kunter, E.M. Sicking, C.R. van Roeyen, S.K. Sanden, M. Kaldenbach, P. Boor, A. Fuss, S. Uhlig, R. Lanzmich, B. Willemsen, H. Dijkman, M. Grepl, K. Wild, W. Kriz, B. Smeets, J. Floege, and M.J. Moeller Albumin is recycled from the primary urine by tubular transcytosis J. Am. Soc. Nephrol. 24 2013 1966 1980
40. A.M. Abdelrahman, S. Al Salam, A.S. AlMahruqi, I.S. Al husseni, M.A. Mansour, and B.H. Ali N-acetylcysteine improves renal hemodynamics in rats with cisplatin-induced nephrotoxicity J. Appl. Toxicol. 30 2010 15 21
41. D.T. Dickey, Y.J. Wu, L.L. Muldoon, and E.A. Neuwelt Protection against cisplatin-induced toxicities by N-acetylcysteine and sodium thiosulfate as assessed at the molecular, cellular, and in vivo levels J. Pharmacol. Exp. Ther. 314 2005 1052 1058 (Pubitemid 41205968)